Polymeric Drug Carriers Research Articles

Electrospun composite membranes of ethyl cellulose and MXene (Ti3C2Tx): Biocompatible platforms for enhanced drug delivery and antibacterial wound healing.

Ethyl cellulose (EC), a degradable cellulose derivative, served as a primary component in membranes fabricated by electrospinning for in vitro drug delivery applications. An effective strategy to enhance drug release was incorporating high-surface-area nanomaterials into polymeric drug carriers, which facilitated drug attachment to both the polymer matrix and additive surfaces, promoting release. MXene (Ti3C2Tx) demonstrated promising potential in improving tensile mechanical properties, antibacterial activity, and curcumin (Cur) release performance of EC membrane. Compared to Cur-loaded EC/MXene membranes, the toughness of Cur-loaded EC-based carriers significantly increased by 53.58%, reaching 3.821kJ/m3. This composite membrane exhibited exceptional antibacterial efficacy, notably reducing Staphylococcus aureus colonies by 52.4×107CFU/mL after 168h, through the dilution spread plate method. Using MTT assay, the composite membrane demonstrated biocompatibility, as evidenced by >70% viability of mouse fibroblast L929 cells with observable cell attachment after 168h. Importantly, the EC/MXene membrane achieved a Cur release amount of 69.82% compared to 7.11% from Cur-loaded EC membranes within 168h, representing a 62.71% enhancement in Cur release. The EC/MXene composite membrane is a promising drug delivery candidate, particularly for Cur, by utilizing the sustainability of EC as the primary drug carrier component.

A review on in situ gels as polymer drug carriers in the treatment of periodontitis

A review on in situ gels as polymer drug carriers in the treatment of periodontitis

Novel poly(2-ethyl-2-oxazoline) and poly(diallyldimethylammonium chloride) polymer functionalized montmorillonite: Physicochemical aspects and near-IR study of hydration properties

The novel functionalized montmorillonites (Mts) with non-ionic poly(2-ethyl-2-oxazoline) (PEtOx) and cationic poly(diallyldimethylammonium) (PDDA) were created via an intercalation method with different loading ratio of both polymers. A comprehensive investigation into their physicochemical properties was conducted using Carbon analysis (CA), Powder X-ray diffraction (PXRD), Fourier-transform infrared spectroscopy (FTIR), Simultaneous thermal analysis (TGA/DSC) and BET-N2 adsorption analysis. The impact of hydration on PEtOx-Mts and PDDA-Mts was assessed through gravimetric analysis and near-infrared spectroscopy (NIR) spectroscopy. PXRD analysis revealed a significant increase in 001 diffraction of PDDA-Mt corresponding to a PDDA interlayer with a basal spacing ranging from 1.47 to 1.49 nm. Conversely, the basal spacing exceeding 2 nm for PEtOx suggested, that the PEtOx polymer was intercalated in a larger amount and packed in a less compact manner compared to PDDA. After modification of Na-Mt with PEtOx polymer, FTIR spectroscopy confirmed the presence of the carbonyl CO group (3265 and 1641 cm-1) and the stretching (2982, 2942 and 2883 cm-1) and bending (1480–1200 cm-1) vibrations of the CH2 and CH3 groups. The vibrations of CH groups were further verified following PDDA modification. NIR spectroscopy also confirmed the vibrational bands attributed to both modifiers after intercalation of PEtOx and PDDA. The results of BET-N2 adsorption revealed a significant decrease in the specific surface area (SSA) after intercalation with a non-ionic PEtOx polymer. On the contrary, in the case of saturation of Na-Mt with polycation PDDA, SSA increased slightly in two instances. TGA analysis confirmed greater weight loss for PEtOx-Mts compared to PDDA-Mts. Derivative thermogravimetry (DTG) revealed the release of physisorbed bound water around 100 °C, decomposition of the organic phase within the 250–550 °C range and dehydroxylation of OH groups around 550–800 °C in both cases. The results obtained from the gravimetry and NIR analysis indicated a greater hydrophobic nature for PEtOx-Mts compared to PDDA-Mts. These findings hold substantial potential for enhancing the properties of novel organo-montmorillonites, thereby facilitating their application as adsorbents for pollutants, surface coatings, biodegradable materials, fillers in polymer nanocomposites, drug carriers, anticancer agents and various other significant applications.

RGD-coated polymeric microbubbles promote ultrasound-mediated drug delivery in an inflamed endothelium-pericyte co-culture model of the blood-brain barrier

Drug delivery to central nervous pathologies is compromised by the blood-brain barrier (BBB). A clinically explored strategy to promote drug delivery across the BBB is sonopermeation, which relies on the combined use of ultrasound (US) and microbubbles (MB) to induce temporally and spatially controlled opening of the BBB. We developed an advanced in vitro BBB model to study the impact of sonopermeation on the delivery of the prototypic polymeric drug carrier pHPMA as a larger molecule and the small molecule antiviral drug ribavirin. This was done under standard and under inflammatory conditions, employing both untargeted and RGD peptide-coated MB. The BBB model is based on human cerebral capillary endothelial cells and human placental pericytes, which are co-cultivated in transwell inserts and which present with proper transendothelial electrical resistance (TEER). Sonopermeation induced a significant decrease in TEER values and facilitated the trans-BBB delivery of fluorescently labeled pHPMA (Atto488-pHPMA). To study drug delivery under inflamed endothelial conditions, which are typical for e.g. tumors, neurodegenerative diseases and CNS infections, tumor necrosis factor (TNF) was employed to induce inflammation in the BBB model. RGD-coated MB bound to and permeabilized the inflamed endothelium-pericyte co-culture model, and potently improved Atto488-pHPMA and ribavirin delivery. Taken together, our work combines in vitro BBB bioengineering with MB-mediated drug delivery enhancement, thereby providing a framework for future studies on optimization of US-mediated drug delivery to the brain.Graphical abstract

Closing the Gap between Experiment and Simulation─A Holistic Study on the Complexation of Small Interfering RNAs with Polyethylenimine.

Rational design is pivotal in the modern development of nucleic acid nanocarrier systems. With the rising prominence of polymeric materials as alternatives to lipid-based carriers, understanding their structure-function relationships becomes paramount. Here, we introduce a newly developed coarse-grained model of polyethylenimine (PEI) based on the Martini 3 force field. This model facilitates molecular dynamics simulations of true-sized PEI molecules, exemplified by molecules with molecular weights of 1.3, 5, 10, and 25 kDa, with degrees of branching between 50.0 and 61.5%. We employed this model to investigate the thermodynamics of small interfering RNA (siRNA) complexation with PEI. Our simulations underscore the pivotal role of electrostatic interactions in the complexation process. Thermodynamic analyses revealed a stronger binding affinity with increased protonation, notably in acidic (endosomal) pH, compared to neutral conditions. Furthermore, the molecular weight of PEI was found to be a critical determinant of binding dynamics: smaller PEI molecules closely enveloped the siRNA, whereas larger ones extended outward, facilitating the formation of complexes with multiple RNA molecules. Experimental validations, encompassing isothermal titration calorimetry and single-molecule fluorescence spectroscopy, aligned well with our computational predictions. Our findings not only validate the fidelity of our PEI model but also accentuate the importance of in silico data in the rational design of polymeric drug carriers. The synergy between computational predictions and experimental validations, as showcased here, signals a refined and precise approach to drug carrier design.

Engineering lauric acid-based nanodrug delivery systems for restoring chemosensitivity and improving biocompatibility of 5-FU and OxPt against Fn-associated colorectal tumor.

Colorectal cancer (CRC) occurs in the colorectum and ranks second in the global incidence of all cancers, accounting for one of the highest mortalities. Although the combination chemotherapy regimen of 5-fluorouracil (5-FU) and platinum(IV) oxaliplatin prodrug (OxPt) is an effective strategy for CRC treatment in clinical practice, chemotherapy resistance caused by tumor-resided Fusobacterium nucleatum (Fn) could result in treatment failure. To enhance the efficacy and improve the biocompatibility of combination chemotherapy, we developed an antibacterial-based nanodrug delivery system for Fn-associated CRC treatment. A tumor microenvironment-activated nanomedicine 5-FU-LA@PPL was constructed by the self-assembly of chemotherapeutic drug derivatives 5-FU-LA and polymeric drug carrier PPL. PPL is prepared by conjugating lauric acid (LA) and OxPt to hyperbranched polyglycidyl ether. In principle, LA is used to selectively combat Fn, inhibit autophagy in CRC cells, restore chemosensitivity of 5-FU as well as OxPt, and consequently enhance the combination chemotherapy effects for Fn-associated drug-resistant colorectal tumor. Both in vitro and in vivo studies exhibited that the tailored nanomedicine possessed efficient antibacterial and anti-tumor activities with improved biocompatibility and reduced non-specific toxicity. Hence, this novel anti-tumor strategy has great potential in the combination chemotherapy of CRC, which suggests a clinically relevant valuable option for bacteria-associated drug-resistant cancers.

Tuning the Emulsion Properties Influences the Size of Poly(Caprolactone) Particles for Drug Delivery Applications.

Advances in drug delivery have been accelerated with the addition of polymeric drug carriers. Direct delivery to a target site is a promising step in developing effective drug and gene therapies to treat disease. The efficacy of these drug carriers heavily relies on cell uptake without compromising critical cellular processes that promote cell viability. Drug release from biodegradable polymers is mediated largely by polymer degradation, and therefore the rate of polymer degradation dictates the feasibility of drug delivery applications. Traditionally, poly(caprolactone) (PCL) has only been used in long-term biomedical applications because the degradation time is much slower than other polymers. However, the biocompatibility of this polymer and the potential for longer delivery windows renders it a promising polymer candidate for drug delivery. In this work, we outline sixteen emulsion solvent evaporation preparation methods for PCL nanoparticles and microparticles to develop particles between 300nm and 1.7μm and with zeta potentials of -1.8mV. We further investigated particles in a size range suitable for systemic tumor delivery and inhaled aerosol delivery to determine cell biocompatibility with the polymer in lung adenocarcinoma, endometrial adenocarcinoma, and human embryonic kidney cells. We determined these particles aren't detrimental to cell viability below particle monolayer coverage atop cells and therefore these formulations hold promise for the next stage of development as sustained-release drug delivery carriers.

Cationic Dextran Stearate (Dex-St-GTMAC): Synthesis and Evaluation as Polymeric Micelles for Indomethacin Corneal Penetration.

Background Indomethacin as a non-steroidal anti-inflammatory drug (NSAID) is commonly used to treat some ocular inflammatory disorders. Unfortunately, indomethacin is a drug that is poorly soluble in water; therefore, it has low efficacy. An attractive approach is the targeted delivery of indomethacin to the cornea using cationic dextran stearate as a polymeric micelle drug carrier. Methods A dextran stearate-glycidyl trimethylammonium chloride (Dex-St-GTMAC) copolymer was prepared through the reaction of GTMAC, stearoyl chloride, and dextran. Then, Dex-St-GTMAC was characterized by Fourier transform infrared (FT-IR) spectroscopy and 1H NMR spectroscopy. Dex-St-GTMAC forms micelles in the presence of indomethacin. The prepared polymeric micelles were characterized for size, ζ-potential, drug loading, particle morphology, critical micelle concentration, and encapsulation efficiency. To study the irritation potential of the indomethacin-loaded Dex-St-GTMAC, Het-Cam and Draize tests have been performed. Prepared cationic micelles were subjected to the in vitro drug release and ex vivotrans-corneal permeation test. Results The dialysis method was used for the preparation of indomethacin-loaded micelles (10, 20, and 30%). Measurement of the particle size showed a mean diameter of 122.1 and 150.9 nm for the drug-loaded micelles. Scanning electron microscopy (SEM) images showed that the morphology of the particles is spherical. 10% formulation was chosen as the best formulation due to more surface charge and reasonable drug loading. ζ-potential measurement for the 10% drug-containing micelles showed a value of +39.1 mV. Drug loading efficiency and the encapsulation efficiency for 10% drug-containing micelles were 6.36 and 63.61%, respectively. The results of the Het-Cam and Draize tests indicated that the indomethacin-loaded Dex-St-GTMAC formulation had no toxicity to eye tissues. Based on our results, the prepared micelles (indomethacin-loaded Dex-St-GTMAC) exhibited a sustained drug release pattern compared to the control group. Indomethacin penetration from the micelles to the excised bovine cornea was 1.75-fold greater than the control (indomethacin 0.1% in phosphate-buffered saline (PBS)). Conclusions Data from the ζ-potential, SEM, drug loading capacity, and in vitro drug release studies indicated that cationic dextran stearate polymeric micelles are an appropriate carrier for the efficient penetration of indomethacin into cornea tissues.

Preparation of acid-sensitive polymeric oncology drug carriers and analysis of effectiveness

Gambogic acid (GA) and combretastatin A-4 (CA-4) were used as antitumor drugs to prepare three-armed polymers (TPs) by reversible addition–fragmentation chain-transfer polymerization, atom-transfer radical polymerization and click polymerization. Gel permeation chromatography characterization showed that the molecular weights of glucose cyanine 7.5 (Cy7.5), carboxyl-terminated chain transfer agent (C7A) and polyethylene glycol (PEG) in CTA-PEG5k-Lys-AzMA-Cy7.5-C7A TP were 5000. The grain size of GA and CA-4 embedded in 10 mg TP and linear polymer (LP) is 3.2 mg. The toxicity of CA-4 is low, while the toxicity of GA is high. For the LP and TP, a higher apoptosis rate is produced under laser irradiation. The polymers are aggregated at the tumor site, which indicates that the polymer system has a better in vivo distribution effect, and the aggregation effect of the TP is better than that of the LP. The TP prepared by this research has good antitumor effect and biological effect and can be popularized and applied in the targeted treatment of tumor diseases.

Fabrication of PEG-PLGA Microparticles with Tunable Sizes for Controlled Drug Release Application.

Polymeric microparticles of polyethyleneglycol-polylactic acid-co-glycolic acid (PEG-PLGA) are widely used as drug carriers for a variety of applications due to their unique characteristics. Although existing techniques for producing polymeric drug carriers offer the possibility of achieving greater production yield across a wide range of sizes, these methods are improbable to precisely tune particle size while upholding uniformity of particle size and morphology, ensuring consistent production yield, maintaining batch-to-batch reproducibility, and improving drug loading capacity. Herein, we developed a novel scalable method for the synthesis of tunable-sized microparticles with improved monodispersity and batch-to-batch reproducibility via the coaxial flow-phase separation technique. The study evaluated the effect of various process parameters on microparticle size and polydispersity, including polymer concentration, stirring rate, surfactant concentration, and the organic/aqueous phase flow rate and volume ratio. The results demonstrated that stirring rate and polymer concentration had the most significant impact on the mean particle size and distribution, whereas surfactant concentration had the most substantial impact on the morphology of particles. In addition to synthesizing microparticles of spherical morphology yielding particle sizes in the range of 5-50 µm across different formulations, we were able to also synthesize several microparticles exhibiting different morphologies and particle concentrations as a demonstration of the tunability and scalability of this method. Notably, by adjusting key determining process parameters, it was possible to achieve microparticle sizes in a comparable range (5-7 µm) for different formulations despite varying the concentration of polymer and volume of polymer solution in the organic phase by an order of magnitude. Finally, by the incorporation of fluorescent dyes as model hydrophilic and hydrophobic drugs, we further demonstrated how polymer amount influences drug loading capacity, encapsulation efficiency, and release kinetics of these microparticles of comparable sizes. Our study provides a framework for fabricating both hydrophobic and hydrophilic drug-loaded microparticles and elucidates the interplay between fabrication parameters and the physicochemical properties of microparticles, thereby offering an itinerary for expanding the applicability of this method for producing polymeric microparticles with desirable characteristics for specific drug delivery applications.

Stabilization of Essential Oil: Polysaccharide-Based Drug Delivery System with Plant-like Structure Based on Biomimetic Concept.

Essential oils (EOs) have stability problems, including volatility, oxidation, photosensitivity, heat sensitivity, humidity sensitivity, pH sensitivity, and ion sensitivity. A drug delivery system is an effective way to stabilize EOs, especially due to the protective effect of polymeric drug carriers. Polysaccharides are frequently employed as drug carrier materials because they are highly safe, come in a variety of forms, and have plentiful sources. Interestingly, the EO drug delivery system is based on the biomimetic concept since it corresponds to the structure of plant tissue. In this paper, we associate the biomimetic plant-like structures of the EO drug delivery system with the natural forms of EO in plant tissues, and summarize the characteristics of polysaccharide-based drug carriers for EO protection. Thus, we highlight the research progress on polysaccharides and their modified materials, including gum arabic, starch, cellulose, chitosan, sodium alginate, pectin, and pullulan, and their use as biomimetic drug carriers for EO preparations due to their abilities and potential for EO protection.

Production and Characterization of Colon Targeted pH Sensitive Macrospheres and Investıgation of Release Kinetics

The gastrointestinal track has different pH values at different sections. Thus, it is not easy to carry a drug to the colon for absorption. pH sensitive polymeric macrosphere drug carriers have important advantages such as being able to be taken orally, targeting the active ingredient to the desired area and dosing the active ingredient at the desired concentration for a long time in the target area. In this contex pH sensitive sodium alginate-gelatin macrospheres were produced by the dispersion phase gelling and cross-linking (complex coacervation) process method then loaded with Sternbergia lutea extract in this study. The macrosphere extract release kinetics were investigated for different pH medias that simulates different sections of the gastrointestinal track. As a result, the produced drug carrier macrospheres released the active ingredient at the colon pH (pH 7.0) while at lower pH values did not show a significant extract release. Therefore, it was reported that the produced macrospheres have potential to be used for colon diseases treatments.

Polycondensation of Acid anhydrides with Asparaginyl Imide Diamine and Curing with Styrene as Smart Polymers for Sustained Release Drug Delivery System

Polymers can provide new and effective ways of administering drugs and enhance therapeutic efficacy. Polymers also present a means for controlled delivery of several drugs in the form of polymeric drug carriers or polymeric prodrugs. Our study involved synthesize of new condensed polymers from reacting of unsaturated acid anhydride such as maleic or methylnadic anhydrides, with prepared N-asparaginyl imide diamine, which prepared from reacting of asparaginyl chloride with ammonia. The new condensed polymers were curing with styrene and the cross-linked polymers were obtained with high conversion percent. The physical properties were measured and all the prepared monomers and polymers were characterized by FT-IR and UV spectroscopy. The intrinsic viscosity was calculated and swelling index was measured for the prepared cross-linked polymers. The inserted asparagine as amino acid could enhance the biodegradability properties, and these prepared bioactive polymers can be used as biomaterial in different applications, which could be acted as smart polymers due to pH sensitivity.

Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery

Nanomedicine is currently focused on the design and development of nanocarriers that enhance drug delivery to the brain to address unmet clinical needs for treating neuropsychiatric disorders and neurological diseases. Polymer and lipid-based drug carriers are advantageous for delivery to the central nervous system (CNS) due to their safety profiles, drug-loading capacity, and controlled-release properties. Polymer and lipid-based nanoparticles (NPs) are reported to penetrate the blood-brain barrier (BBB) and have been extensively assessed in in vitro and animal models of glioblastoma, epilepsy, and neurodegenerative disease. Since approval by the Food and Drug Administration (FDA) of intranasal esketamine for treatment of major depressive disorder, intranasal administration has emerged as an attractive route to bypass the BBB for drug delivery to the CNS. NPs can be specifically designed for intranasal administration by tailoring their size and coating with mucoadhesive agents or other moieties that promote transport across the nasal mucosa. In this review, unique characteristics of polymeric and lipid-based nanocarriers desirable for drug delivery to the brain are explored in addition to their potential for drug repurposing for the treatment of CNS disorders. Progress in intranasal drug delivery using polymeric and lipid-based nanostructures for the development of treatments of various neurological diseases are also described.

Effect of Cellular and Microenvironmental Multidrug Resistance on Tumor-Targeted Drug Delivery in Triple-Negative Breast cancer.

Multidrug resistance (MDR) reduces the efficacy of chemotherapy. Besides inducing the expression of drug efflux pumps, chemotherapy treatment alters the composition of the tumor microenvironment (TME), thereby potentially limiting tumor-directed drug delivery. To study the impact of MDR signaling in cancer cells on TME remodeling and nanomedicine delivery, we generated multidrug-resistant 4T1 triple-negative breast cancer (TNBC) cells by exposing sensitive 4T1 cells to gradually increasing doxorubicin concentrations. In 2D and 3D cell cultures, resistant 4T1 cells are presented with a more mesenchymal phenotype and produced increased amounts of collagen. While sensitive and resistant 4T1 cells showed similar tumor growth kinetics in vivo, the TME of resistant tumors was enriched in collagen and fibronectin. Vascular perfusion was also significantly increased. Fluorophore-labeled polymeric (∼10nm) and liposomal (∼100nm) drug carriers were administered to mice with resistant and sensitive tumors. Their tumor accumulation and penetration were studied using multimodal and multiscale optical imaging. At the whole tumor level, polymers accumulate more efficiently in resistant than in sensitive tumors. For liposomes, the trend was similar, but the differences in tumor accumulation were insignificant. At the individual blood vessel level, both polymers and liposomes were less able to extravasate out of the vasculature and penetrate the interstitium in resistant tumors. In a final in vivo efficacy study, we observed a stronger inhibitory effect of cellular and microenvironmental MDR on liposomal doxorubicin performance than free doxorubicin. These results exemplify that besides classical cellular MDR, microenvironmental drug resistance features should be considered when aiming to target and treat multidrug-resistant tumors more efficiently.

Preparation and Optimization of Poly-Tannic Acid Nanoparticles as Potential Polymeric Drug or Drug Delivery Carrier

Tannic acid (TA), as a common natural catechol derivative, has been widely applied as antibacterial drug or in the construction of carriers for drug delivery with metal ions. However, unlike dopamine, another catechol derivative whose polymerized form of nanoparticles have been successfully constructed and adopted in various biomedical fields, the development of poly-TA nanoparticles (PTANPs) is rarely reported and the optimization studies are even less. Therefore, the understanding of details and information regarding to the synthesis of PTANPs can provide insights into the polymerization process of TA and inspire the development of other catechol derivatives based nanoscale platforms for diverse scientific applications. Herein, we used a typical sodium hydroxide (NaOH) triggered polymerization followed by hydrogen peroxide (H2O2) degradation to prepare PTANPs. In our study, we explored the impact of temperature, weight/volume of reactants (TA, NaOH and H2O2) and reaction time (NaOH and H2O2) on the size of finally obtained PTANPs, which can give guidance and inspiration for future researches and facilitate the studies of followers.

Fabrication and Evaluation of Graphene Oxide/Hydroxypropyl Cellulose/Chitosan Hybrid Aerogel for 5-Fluorouracil Release.

The incorporation of graphene oxide (GO) into a polymeric drug carrier can not only enhance the loading efficiency but also reduce the initial burst and consequently improve the controllability of drug release. Firstly, 5-fluorouracil (5-Fu)-loaded hydroxypropyl cellulose/chitosan (HPC/CS@5-Fu) and GO/HPC/CS@5-Fu aerogels were successfully fabricated through chemical cross-linking with glutaraldehyde. Then, the obtained aerogels were characterized using scanning electron microscopy (SEM), Fourier transform infrared (FITR), X-ray diffraction (XRD), differential scanning calorimetry (DSC), thermogravimetry (TG), and the effect of HPC and GO content on the drug loading (DL) and encapsulation efficiency (EE) for the two aerogels were investigated, respectively. Finally, the drug release behavior of the GO/HPC/CS@5-Fu aerogels with different GO content was evaluated at two different pH values, and four kinds of kinetic models were used to evaluate the release behavior.

Effects of polymer molecular weight on in vitro and in vivo performance of nanoparticle drug carriers for lymphoma therapy

The clinical efficacy of chemotherapeutic drugs is hindered by their poor aqueous solubility, low bioavailability and severe side effects. In recent years, polymeric nanocarriers have been used for drug delivery to improve the efficacy of many chemotherapeutics. In this study, a series of biodegradable phenylalanine-based poly(ester amide) (Phe-PEA) with tunable molecular weights (MWs) were synthesized to systematically investigate the relationship between the polymer MW and the efficacy of the corresponding polymeric nanoparticles (NPs). The results indicated that a range of polymers with different MWs can be obtained by varying the monomer ratio or reaction time. Doxorubicin (DOX), a classic clinical lymphoma treatment strategy, was selected as a model drug. The loading capacity and stability of the higher MW polymeric NPs were superior to those of the lower MW ones. Moreover, in vitro and in vivo data revealed that high MW polymeric NPs had better anticancer efficacy against lymphoma and higher biosafety than low MW polymeric nanoparticles and DOX. Therefore, this study suggests the importance of polymer MW for drug delivery systems and provides valuable guidance for the design of enhanced polymeric drug carriers for lymphoma treatment.

An appraisal of polymers of DES technology and their impact on drug release kinetics

Drug-eluting stents (DES) are the best choice of the current era to open the occluded arteries. Its success depends upon the concentration of the drug and overall release kinetics, which in turn is subjected to the polymeric drug carrier and mechanism of drug release at the target area. Each generation of DES possess different characteristics based on different aspects i.e., polymer type, coating layer thickness, and drug concentration have been discussed. This review paper discusses all the polymers utilized in DES systems and their release profiles when combined with multiple drugs for the treatment of coronary heart disease.

PRODUCTION OF GANODERMA LUCIDUM EXTRACT LOADED GELATIN-SODIUM ALGINATE MICROSPHERES, INVESTIGATION OF RELEASE KINETICS AT DIFFERENT pH VALUES AND EVALUATION OF KINETIC MODELS

In this study, pH sensitive microsphere polymeric drug carriers were produced by using biodegradable natural gelatin and sodium alginate polymers. Microspheres were loaded with prepared Ganoderma lucidum extract that is a medicinal mushroom and has the potential to be used in several diseases’ treatment. Extract release kinetics of the microspheres were examined by spectrophotometric method by using an UV spectrometer. Buffer solutions with different pH values were used as release medium for examination of drug release kinetics of the produced microspheres. The Ganoderma lucidum release of microspheres was presented in terms of percent cumulative release (CR%) defined as the percentage ratio of the instantaneous amount of Ganoderma lucidum released at a certain time of incubation to the initial amount of Ganoderma lucidum loadings. As a result, it was seen that the release of the extract accelerated as pH of the release medium increased and the fastest extract release was observed in the pH 7. The release kinetic models of the microspheres were examined. The release kinetics of microspheres fitted Higuchi model for pH 1.3, pH 5.0 and pH 6.0 and first-order model for pH 3.0 and pH 7.0.